Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis

被引:34
作者
Andereya, S
Streich, N
Schmidt-Rohlfing, B
Mumme, T
Müller-Rath, R
Schneider, U
机构
[1] Aachen Univ Hosp, Dept Orthopaed Surg, D-52074 Aachen, Germany
[2] Univ Heidelberg, Dept Orthopaed Surg, Heidelberg, Germany
关键词
MMP-13; osteoarthritis; rheumatoid arthritis; synovial fluid; serum;
D O I
10.1007/s00296-005-0006-2
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Numerous studies have focused on the significance of modern marker proteins in the synovial fluid of the knee joint and in the serum both, for osteoarthritis ( OA) and rheumatoid arthritis ( RA). The relationship between the serum concentrations and the concentrations in the synovial fluid is still unclear. Synovial fluid and serum samples were obtained from 13 patients with advanced OA and from 8 patients with severe RA and concentrations of MMP-1, MMP-3, MMP-13, TIMP-1, COMP and MIA/CD-RAP were determined. All values were normalized against the total protein concentrations. Serum concentrations of MMP-13 in the RA-group were statistically higher than the synovial values ( P < 0.05). MMP-13 was the only marker protein that revealed distinct higher levels in the serum than in the synovial fluid. The study design allows only conclusions about advanced stages of RA and OA. Longitudinal investigations may provide further information about the value of MMP-13 as a potential marker to monitor the course of RA and OA.
引用
收藏
页码:432 / 438
页数:7
相关论文
共 41 条
[21]
MACNAUL KL, 1990, J BIOL CHEM, V265, P17238
[22]
MARTELPELLETIER J, 1994, LAB INVEST, V70, P807
[23]
Cartilage oligomeric matrix protein (COMP):: The role of a non-collagenous cartilage matrix protein as a marker of disease activity and joint destruction in RA-and OA-patients [J].
Marti, C ;
Neidhart, M ;
Gerber, T ;
Hauser, N ;
Michel, BA ;
Häuselmann, HJ .
ZEITSCHRIFT FUR RHEUMATOLOGIE, 1999, 58 (02) :79-87
[25]
Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage [J].
Mitchell, PG ;
Magna, HA ;
Reeves, LM ;
LoprestiMorrow, LL ;
Yocum, SA ;
Rosner, PJ ;
Geoghegan, KF ;
Hambor, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :761-768
[26]
MIA (melanoma inhibitory activity):: a potential serum marker for rheumatoid arthritis [J].
Müller-Ladner, U ;
Bosserhoff, AK ;
Dreher, K ;
Hein, R ;
Neidhart, M ;
Gay, S ;
Schölmerich, J ;
Buettner, R ;
Lang, B .
RHEUMATOLOGY, 1999, 38 (02) :148-154
[27]
Nagase H, 1997, BIOL CHEM, V378, P151
[28]
Nagase H., 1993, JOINT CARTILAGE DEGR, P159
[29]
Nagase H, 1995, TXB RHEUMATOLOGY, P323
[30]
Practical aspects of cytokine-determination in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and other joint-diseases [J].
Neidel, J ;
Schulze, M ;
Sova, L ;
Lindschau, J .
ZEITSCHRIFT FUR ORTHOPADIE UND IHRE GRENZGEBIETE, 1996, 134 (04) :381-385